DaVita (DVA) | Financial Analysis & Statements
DaVita Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
3.6B
Gross Profit
1.2B
33.43%
Operating Income
551.2M
15.23%
Net Income
331.0M
9.15%
EPS (Diluted)
$3.29
Balance Sheet Metrics
Total Assets
17.5B
Total Liabilities
16.3B
Shareholders Equity
1.2B
Debt to Equity
14.09
Cash Flow Metrics
Operating Cash Flow
489.8M
Free Cash Flow
395.3M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
DaVita Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 13.6B | 12.8B | 12.1B | 11.6B | 11.6B |
| Cost of Goods Sold | 9.2B | 8.6B | 8.3B | 8.2B | 8.0B |
| Gross Profit | 4.4B | 4.2B | 3.8B | 3.4B | 3.6B |
| Gross Margin % | 32.2% | 32.9% | 31.5% | 29.3% | 31.4% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.7B | 1.5B | 1.5B | 1.4B | 1.2B |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 1.7B | 1.5B | 1.5B | 1.4B | 1.2B |
| Operating Income | 2.0B | 2.0B | 1.6B | 1.3B | 1.8B |
| Operating Margin % | 14.7% | 15.3% | 13.2% | 11.3% | 15.2% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 579.9M | 470.5M | 398.6M | 357.0M | 285.3M |
| Other Non-Operating Income | -83.9M | 46.0M | -25.4M | 10.8M | 33.3M |
| Pre-tax Income | 1.3B | 1.5B | 1.2B | 966.3M | 1.5B |
| Income Tax | 293.1M | 279.7M | 220.1M | 198.1M | 306.7M |
| Effective Tax Rate % | 21.8% | 18.3% | 18.7% | 20.5% | 20.2% |
| Net Income | 1.1B | 1.3B | 957.0M | 781.6M | 1.2B |
| Net Margin % | 7.9% | 9.8% | 7.9% | 6.7% | 10.4% |
| Key Metrics | |||||
| EBITDA | 2.7B | 2.6B | 2.4B | 2.1B | 2.5B |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Basic Shares Outstanding | 74227000 | 84991000 | 90790000 | 92992000 | 105230000 |
| Diluted Shares Outstanding | 74227000 | 84991000 | 90790000 | 92992000 | 105230000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
DaVita Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 676.4M | 794.9M | 380.1M | 244.1M | 461.9M |
| Short-term Investments | 24.3M | 51.1M | 11.6M | 77.7M | 22.3M |
| Accounts Receivable | 2.4B | 2.1B | 2.0B | 2.1B | 2.0B |
| Inventory | 160.6M | 134.6M | 143.1M | 109.1M | 107.4M |
| Other Current Assets | 156.3M | 122.9M | 102.6M | 78.8M | 72.5M |
| Total Current Assets | 4.1B | 3.7B | 3.1B | 3.2B | 3.2B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 6.9B | 6.8B | 6.6B | 6.4B | 6.1B |
| Goodwill | 15.3B | 14.9B | 14.4B | 14.3B | 14.3B |
| Intangible Assets | 222.1M | 197.4M | 203.2M | 182.7M | 177.7M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 246.5M | 261.7M | 271.3M | 315.6M | 136.7M |
| Total Non-Current Assets | 13.4B | 13.5B | 13.8B | 13.8B | 14.0B |
| Total Assets | 17.5B | 17.3B | 16.9B | 16.9B | 17.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 696.1M | 547.2M | 514.5M | 479.8M | 402.0M |
| Short-term Debt | 534.7M | 681.3M | 517.7M | 626.8M | 573.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 642.3M | 731.6M | 671.2M | 657.1M | 579.1M |
| Total Current Liabilities | 3.1B | 3.0B | 2.6B | 2.6B | 2.4B |
| Non-Current Liabilities | |||||
| Long-term Debt | 12.3B | 11.4B | 10.6B | 11.2B | 11.4B |
| Deferred Tax Liabilities | 756.9M | 665.4M | 726.2M | 782.8M | 831.0M |
| Other Non-Current Liabilities | 83.5M | 169.6M | 183.1M | 105.2M | 119.2M |
| Total Non-Current Liabilities | 13.2B | 12.2B | 11.5B | 12.1B | 12.4B |
| Total Liabilities | 16.3B | 15.2B | 14.2B | 14.7B | 14.8B |
| Equity | |||||
| Common Stock | 69.0K | 90.0K | 89.0K | 90.0K | 97.0K |
| Retained Earnings | -328.4M | 1.5B | 598.3M | 174.5M | 354.3M |
| Treasury Stock | 199.9M | 1.4B | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.2B | 2.1B | 2.7B | 2.2B | 2.4B |
| Key Metrics | |||||
| Total Debt | 12.9B | 12.1B | 11.1B | 11.8B | 12.0B |
| Working Capital | 916.4M | 772.7M | 495.7M | 535.5M | 769.2M |
Balance Sheet Composition
DaVita Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.1B | 1.3B | 957.0M | 781.6M | 1.2B |
| Depreciation & Amortization | 715.3M | 723.9M | 745.4M | 732.6M | 680.6M |
| Stock-Based Compensation | 140.0M | 102.8M | 112.4M | 95.4M | 102.2M |
| Working Capital Changes | -263.2M | -29.8M | 194.5M | 101.0K | -140.6M |
| Operating Cash Flow | 1.7B | 2.0B | 2.0B | 1.6B | 1.9B |
| Investing Activities | |||||
| Capital Expenditures | -575.9M | -555.4M | -568.0M | -603.4M | -641.5M |
| Acquisitions | -144.5M | -251.3M | -302.6M | -89.2M | -201.0M |
| Investment Purchases | -22.4M | -24.5M | -46.7M | -133.4M | -33.8M |
| Investment Sales | 52.1M | 27.2M | 110.0M | 74.9M | 27.9M |
| Investing Cash Flow | -656.5M | -778.1M | -776.7M | -634.3M | -787.7M |
| Financing Activities | |||||
| Share Repurchases | -1.8B | -1.4B | -320.3M | -839.6M | -1.6B |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 5.6B | 6.6B | 2.5B | 2.4B | 1.6B |
| Debt Repayment | -4.8B | -5.5B | -3.0B | -2.4B | -861.1M |
| Financing Cash Flow | -1.4B | -816.9M | -1.2B | -1.1B | -1.1B |
| Free Cash Flow | 1.3B | 1.5B | 1.5B | 961.1M | 1.3B |
| Net Change in Cash | -314.8M | 408.1M | 13.8M | -199.6M | 55.0M |
Cash Flow Trend
DaVita Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
16.32
Forward P/E
9.45
Price to Book
9.13
Price to Sales
0.75
PEG Ratio
2.88
Profitability Ratios
Profit Margin
5.47%
Operating Margin
15.23%
Return on Equity
64.85%
Return on Assets
7.32%
Financial Health
Current Ratio
1.29
Debt to Equity
1,111.35
Beta
0.92
Per Share Data
EPS (TTM)
$9.50
Book Value per Share
$-9.50
Revenue per Share
$183.80
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| DVA | 10.0B | 16.32 | 9.13 | 64.85% | 5.47% | 1,111.35 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Universal Health | 11.1B | 7.84 | 1.52 | 21.33% | 8.57% | 69.73 |
| Ensign Group | 11.1B | 32.78 | 4.95 | 16.90% | 6.80% | 98.70 |
| Encompass Health | 10.2B | 18.52 | 4.21 | 24.82% | 9.54% | 82.85 |
Financial data is updated regularly. All figures are in the company's reporting currency.






